Cuprina Holdings Ltd (CUPR) - Kapitalizatsiyaning foydaga nisbati

Cuprina Holdings Limited (CUPR) korporativ emblemasi va logotipi

Cuprina Holdings (Cayman) Ltd (CUPR) kompaniyasining bozor kapitalizatsiyasi tendentsiyasi -3.60 qiymatini namoyish etib, kompaniyani murakkab jarohatlar terapiyasi bo'yicha mutaxassis sifatida tavsiflaydi. Biznes eksklyuziv patentlar va Singapur hukumatining qat'iy nazorati bilan himoyalangan. Uning ekologik strategiyasi biologik parchalanadigan materiallardan foydalanish va bio-chiqindilarni qayta ishlashga asoslangan. Operatsion samaradorlik biomeditsina preparatlari uchun qat'iy harorat nazoratini ta'minlovchi shaxsiy ekspress yetkazib berish tizimi orqali kafolatlanadi.

Cuprina Holdings Limited - CUPR Narx-foyda koeffitsiyenti (davr: 17.05.2025 - 18.11.2026)

Cuprina Holdings Limited (CUPR) kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:Cuprina Holdings (Cayman) Ltd. (CUPR)
Cuprina Holdings Ltd brend mahsuloti

Cuprina Holdings (Cayman) Ltd (CUPR) kompaniyasining Singapur laboratoriya majmuasi sterillik va energetika avtonomiyasini saqlash uchun yuqori xarajatlarni talab qiladi, bu esa bevosita sof foydaga ta'sir ko'rsatadi. Kompaniyaning tarixiy P/E ko'rsatkichini tahlil qilish orqali investor, xarajatlar oshishi natijasida yuzaga kelgan inflyatsiya sharoitida biznesning baholanishi joriy marjalar va investitsiya qilingan kapitaldan daromad olish qobiliyati bilan asoslanganmi yoki yo'qligini aniqlash uchun bozor kapitalizatsiyasining sof foydaga nisbatini baholaydi.

Raqobatdosh kompaniyalar tahlili

Kapitalizatsiyaning foydaga nisbati hcahealthcare.com HCA|Narxning foydaga nisbati Tenet Healthcare (THC)|Fresenius Medical Care - Narx-foyda multiplikatori|Narxning foydaga nisbati Solventum SOLV|Bozor narxining sof foydaga nisbati EHC (Encompass Health)|UHS: Narx-foyda koeffitsiyenti|DVA (DaVita) - Narx-foyda multiplikatori|RadNet Corp (RDNT) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Option Care Corp (OPCH)|Narx-foyda koeffitsiyenti SGRY|PINC: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EYE|PGNY - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori ARDT (ardenthealth.com)|SEM - Narx-foyda koeffitsiyenti|Astrana Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Pennant Group (PNTG)|ORGO (Organogenesis Holdings Inc.) - P/E multiplikatori|NUTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AUNA|Narx-foyda koeffitsiyenti SBC Medical Group Holdings Inc SBC|Narxning foydaga nisbati Jeuveau EOLS|Kompaniya qiymatining sof foydaga nisbati CYH|SKIN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati MDWD (MediWound)|BTMD (biote.com) - Narx-foyda koeffitsiyenti|Narx-foyda koeffitsiyenti thejoint.com|DCGO (DocGo, Inc.) - P/E multiplikatori|Narxning foydaga nisbati PIII|Narx-foyda koeffitsiyenti GANX (Gain Therapeutics Inc.)|P/E multiplikatori EUDA Health (EUDA)|Basel Medical Group - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati CLGN (CollPlant Ltd)|CCM: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AMS (American Shared Hospital Services)|MRM: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Avalon GloboCare Corp (ALBT)|Narxning foydaga nisbati DIH Holding|XAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NIVF|P/E multiplikatori ATI Physical Therapy Inc. (ATIP)|P/E multiplikatori CMAX (caremax.com)|Bozor narxining sof foydaga nisbati KDLY (Kindly Health)|MODV - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati novointegrated.com|SunLink Health Systems (SSY) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti IMAC Holdings Inc